Oneness Biotech Co., Ltd. (TPEX:4743)
54.40
-1.30 (-2.33%)
Apr 17, 2026, 1:30 PM CST
Oneness Biotech Revenue
In the year 2025, Oneness Biotech had annual revenue of 129.12M TWD with 9.49% growth. Oneness Biotech had revenue of 43.20M in the quarter ending December 31, 2025, with 37.56% growth.
Revenue
129.12M
Revenue Growth
+9.49%
P/S Ratio
201.89
Revenue / Employee
3.00M
Employees
43
Market Cap
26.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 129.12M | 11.20M | 9.49% |
| Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
| Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
| Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
| Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunmax Biotechnology | 2.03B |
| Ever Supreme Bio Technology | 1.02B |
| EirGenix | 1.01B |
| Medigen Vaccine Biologics | 613.17M |
| TaiMed Biologics | 611.35M |
| Polaris Group | 40.60M |
| Lumosa Therapeutics | 35.83M |
| AP Biosciences | 32.25M |